Pam Cheng - AstraZeneca PLC EVP Board
| AZN Stock | 11,882 232.00 1.99% |
Insider
Pam Cheng is EVP Board of AstraZeneca PLC
| Age | 55 |
| Phone | 44 20 3749 5000 |
| Web | https://www.astrazeneca.com |
AstraZeneca PLC Management Efficiency
The company has return on total asset (ROA) of 0.0788 % which means that it generated a profit of $0.0788 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1759 %, meaning that it generated $0.1759 on every $100 dollars invested by stockholders. AstraZeneca PLC's management efficiency ratios could be used to measure how well AstraZeneca PLC manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 13 records | INSIDER Age | ||
| Hind Beaujon | Pfeiffer Vacuum Technology | N/A | |
| Marcus Weinhagen | Pfeiffer Vacuum Technology | N/A | |
| Britta Giesen | Pfeiffer Vacuum Technology | 59 | |
| Chester Goodburn | Caledonia Mining | N/A | |
| Benoit Guillaumin | Pfeiffer Vacuum Technology | N/A | |
| P Human | Caledonia Mining | N/A | |
| John Learmonth | Caledonia Mining | 61 | |
| Heide Erickson | Pfeiffer Vacuum Technology | N/A | |
| Dana BSc | Caledonia Mining | 62 | |
| Tobias Stoll | Pfeiffer Vacuum Technology | 50 | |
| S Smith | Caledonia Mining | N/A | |
| Leonet Steyn | Caledonia Mining | N/A | |
| Wolfgang Ehrk | Pfeiffer Vacuum Technology | N/A | |
Management Performance
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0788 |
AstraZeneca PLC Leadership Team
Elected by the shareholders, the AstraZeneca PLC's board of directors comprises two types of representatives: AstraZeneca PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AstraZeneca. The board's role is to monitor AstraZeneca PLC's management team and ensure that shareholders' interests are well served. AstraZeneca PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AstraZeneca PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marc Dunoyer, CEO Officer | ||
| Pam Cheng, EVP Board | ||
| MBA DVM, CEO Director | ||
| Pr Belvisi, Respiratory, Dev | ||
| Aradhana MD, CFO Director | ||
| Katarina Ageborg, Chief Sustainability | ||
| Jeffrey Pott, Chief CHRO | ||
| Ruud Dobber, Executive Unit | ||
| Chris Sheldon, Head Relations | ||
| David Fredrickson, Executive Unit | ||
| Jeffrey JD, Chief CHRO | ||
| Gonzalo Vina, Head Relations | ||
| Andrew Barnett, Head Relations | ||
| Menelas Pangalos, Executive VicePresident | ||
| Leon Wang, Executive President | ||
| Susan MD, Executive Development | ||
| Ruth March, Senior Oncology | ||
| Iskra Reic, Executive International | ||
| Joris Silon, President US |
AstraZeneca Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AstraZeneca PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0788 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 199.59 B | ||||
| Shares Outstanding | 1.55 B | ||||
| Shares Owned By Insiders | 0.04 % | ||||
| Shares Owned By Institutions | 51.40 % | ||||
| Price To Book | 6.16 X | ||||
| Price To Sales | 3.41 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in AstraZeneca Stock
AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.